Clinical value of detection of cervical thin-layer cytology test and high-risk human papilloma virus in patients with cervical cancer and cervical intraepithelial neoplasia
-
摘要: 目的 探讨宫颈癌及宫颈上皮内瘤变患者宫颈液基薄层细胞学检查(TCT)以及高危型人乳头瘤病毒(hrHPV)检测的临床价值。 方法 回顾性分析72例宫颈癌及宫颈上皮内瘤变患者的临床治疗情况。所有患者均采用TCT以及hrHPV检测,分析患者TCT、hrHPV检测的灵敏度、特异度以及与病理检查结果的符合率。 结果 72例患者TCT检测结果正常者42例,占58.3%(42/72), 异常者为30例,占41.7%(30/72)。宫颈上皮内瘤变的TCT与病理学检查结果的符合率为44.2%(19/43), 宫颈癌TCT与病理学检查结果的符合率为72.7%(8/11)。hrHPV检测显示, 52例患者检测结果为阳性,占72.2%(52/72), 20例为阴性,占27.8%(20/72), 宫颈上皮内瘤变hrHPV检测与病理学检查结果的符合率为86.0%(37/43), 宫颈癌TCT检测与病理学检查结果的符合率为90.9%(10/11)。72例患者进行TCT及hrHPV检测后结果显示,联合检测的灵敏度为94.4%, 诊断符合率为90.3%, 显著高于TCT或hrHPV单一检测。 结论 TCT、hrHPV联合检测有助于提高宫颈癌以及宫颈上皮内瘤变患者的检出率。Abstract: Objective To investigate the clinical value of cervical thin-layer cytology test(TCT)and high-risk human papilloma virus(hrHPV)detection in patients with cervical cancer and cervical intraepithelial neoplasia. Methods Clinical therapentic conditions of 72 cervical cancer and cervical intraepithelial neoplasia patients were retrospectively analyzed. All patients performed TCT and hrHPV. The sensitivities and specificities of TCT and hrHPV detection were analyzed, and their coincidence rates with pathological results were analyzed. Results TCT results of 72 patients showed that 42 cases presented normal results, accounting for 58.3%(42/72), and 30 cases were abnormal, accounting for 41.7%(30/72). The rate of TCT detection that was in with pathological results of cervical intraepithelial neoplasia was 44.2%(19/43), the rate of TCT detection that was in with pathological results of cervical cancer was 72.7%(8/11). The hrHPV test results showed that 52 patients were positive, accounting for 72.2%(52/72), and 20 patients were negative, accounting for 27.8%(20/72). The rate of hrHPV detection accordance with pathological results was 86.0%(37/43)in diagnosis of cervical intraepithelial neoplasia and was 90.9%(10/11)by TCT in diagnosis of cervical cancer. The sensitivity and coincidence rate of TCT and hrHPV combined detection were 94.4% and 90.3% respectively, which were significantly higher than TCT or hrHPV detection alone. Conclusion TCT - and hrHPV combined detection can improve the detection rate of patients with cervical cancer and cervical intraepithelial neoplasia.
-
-
胡森阳, 唐雪. 黔江区宫颈上皮内病变妇女HPV高危亚型分布关系[J]. 中国妇幼保健, 2019, 34(20): 4633-4635. 武丽, 李兵, 吴云涛, 等. 广东省农村妇女宫颈癌前病变及宫颈癌影响因素分析[J]. 现代预防医学, 2019, 46(19): 3509-3513. MANGIERI L F L, SENA M M, CEZAR-DOS-SANTOS F, et al. CCR5 genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions[J]. Int J Immunogenet, 2019, 46(5): 331-338.
GANESAN R. HPV-related cervical glandular lesions[J]. Diagn Histopathol, 2018, 24(1): 18-25.
BASU P, TAGHAVI K, HU S Y, et al. Management of cervical premalignant lesions[J]. Curr Probl Cancer, 2018, 42(2): 129-136.
CASTLE P E, MUROKORA D, PEREZ C, et al. Treatment of cervical intraepithelial lesions[J]. Int J Gynecol Obstet, 2017, 138: 20-25.
曾月, 陈梦捷, 覃露, 等. 体液免疫水平与宫颈上皮内病变及早期宫颈癌的相关性[J]. 中国免疫学杂志, 2018, 34(12): 1857-1860. 王帆, 刘荣, 瞿全新. 宫颈随机活检在宫颈高级别病变诊断中的应用[J]. 山东医药, 2019, 59(18): 70-72. CANFELL K. Cervical screening in HPV-vaccinated populations[J]. Climacteric, 2018, 21(3): 227-234.
MAGED A M, SAAD H, SALAH E, et al. Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening[J]. Int J Gynecol Obstet, 2018, 141(3): 332-336.
YALCIN I, SARI M E, SAHIN H, et al. Colposcopic biopsy findings among women with either HPV-16 only or HPV-18 only who have normal cervical cytology[J]. Int J Gynaecol Obstet, 2018, 143(3): 300-305.
WANG, YANG Y Z, DONG W W, et al. Application of human papillomavirus in screening for cervical cancer and precancerous lesions[J]. Asian Pac J Cancer Prev, 2013,14(5): 2979-2982.
刘双玥, 张雯, 马丽莎, 等. 宫颈高级别病变和宫颈癌患者HPV感染状况及基因型分布[J]. 江苏医药, 2019, 45(7): 653-655. 谌琼华. HPV DNA分型检测在宫颈病变及宫颈癌鉴别诊断中的价值[J]. 检验医学, 2019, 34(6): 498-501. 向睿, 王静依, 孟侠, 等. 不同严重程度宫颈组织学病变中宫颈HPV感染检出率及HPV和TCT在宫颈病变筛查中的价值[J]. 中国妇幼保健, 2019, 34(18): 4192-4194. 方莉, 韩瑜, 许媛, 等. 高危型HPV感染与宫颈癌前病变及宫颈癌的相关性研究[J]. 中国实验诊断学, 2019, 23(4): 602-605. 李洋, 李永丽, 王芦萍. HPV感染型别及多重感染对宫颈病变的影响[J]. 中华医院感染学杂志, 2019, 29(22): 3461-3464 , 3472.
GARLAND S M, DIMECH W, COLLIGNON P, et al. The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality[J]. J Pathol Clin Res, 2018, 4(4): 207-212.
NASSEREDDINE H, CHARPENTIER C, BUCAU M, et al. Interest of cytology combined with Xpert HPV and Anyplex ⅡHPV28 Detection human papillomavirus(HPV)typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy[J]. HIV Med, 2018, 19(10): 698-707.
由月兰, 初悦美, 荆翠红, 等. TCT、高危HPV分型检测联合阴道镜检查在宫颈癌筛查中的应用价值[J]. 中国妇幼保健, 2018, 33(2): 452-454. KARES S, VEIJALAINEN O, KHOLOVÁI, et al. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?[J]. APMIS, 2019, 127(11): 710-716.
石杏先, 余立群, 高国兰. 318例高级别宫颈上皮内瘤变及宫颈癌患者的TCT和hrHPV检测分析[J]. 中国肿瘤临床, 2019, 46(2): 73-76. 赵培玉, 陈敖峥, 秦锦龙, 等. CervistaHR-HPVDNA检测联合TCT在宫颈癌筛查中的临床价值[J]. 检验医学, 2017, 32(4): 322-325. 杨国红, 陆欢. HPV-DNA与TCT检测在宫颈上皮内瘤变筛查中的效果分析[J]. 中国妇幼保健, 2019, 34(23): 5406-5408. TIFAOUI N, MAUDELONDE T, COMBECAL J, et al. High-risk HPV detection and associated cervical lesions in a population of French menopausal women[J]. J Clin Virol, 2018, 108: 12-18.
计量
- 文章访问数: 334
- HTML全文浏览量: 126
- PDF下载量: 7
下载:
苏公网安备 32100302010246号
